WHAT PREDICTS A CLINICAL DISCUSSION ABOUT PREP? RESULTS FROM ANALYSIS OF A US NATIONAL COHORT OF HIV-VULNERABLE SEXUAL AND GENDER MINORITIES

被引:4
作者
Carneiro, Pedro B. [1 ]
Frye, Victoria [2 ]
Mirzayi, Chloe [3 ]
Patel, Viraj [4 ]
Lounsbury, David [5 ]
Huang, Terry T-K [6 ]
Sabounchi, Nasim [6 ]
Grov, Christian [1 ,3 ]
机构
[1] CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Community Hlth & Social Sci, New York, NY 10027 USA
[2] CUNY, Sch Med, New York, NY 10027 USA
[3] CUNY, Inst Implementat Sci Populat Hlth, New York, NY 10027 USA
[4] Albert Einstein Coll Med, Montefiore Hlth Syst, Div Gen Internal Med, Bronx, NY 10467 USA
[5] Albert Einstein Coll Med, Montefiore Hlth Syst, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[6] CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Hlth Policy & Management, New York, NY 10027 USA
关键词
PrEP uptake; PrEP assessment; provider communication; HIV prevention; PREEXPOSURE PROPHYLAXIS; MEN;
D O I
10.1521/aeap.2022.34.3.195
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
HIV-outcome inequities remain prevalent in the U.S. Medical providers (MPs) are gatekeepers of PrEP, and understanding the dynamics of PrEP assessments is of major interest for public health. We analyzed data from Together 5000, an internet-based U.S. national cohort of sexual and gender minority (SGM) individuals aged 16-49 years and at risk for HIV. Among those eligible for PrEP uptake (n = 6264), we modeled predictors of discussing PrEP with an MP. A third (31%) of participants had spoken to a MP about PrEP. Among those who spoke to a MP, 45% suggested they would initiate PrEP; this outcome was more common among participants older than 24. With a persistent stagnant uptake nationwide, new opportunities to influence PrEP uptake must be explored. An attractive less targeted space is the medical office, specifically ways to support an initial and continued discussion about PrEP between MPs and their patients.
引用
收藏
页码:195 / 208
页数:14
相关论文
共 31 条
[11]  
King MF, 2000, PSYCHOL MARKET, V17, P79, DOI 10.1002/(SICI)1520-6793(200002)17:2<79::AID-MAR2>3.0.CO
[12]  
2-0
[13]   Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women [J].
Kuhns, Lisa M. ;
Reisner, Sari L. ;
Mimiaga, Matthew J. ;
Gayles, Travis ;
Shelendich, Michael ;
Garofalo, Robert .
AIDS AND BEHAVIOR, 2016, 20 (07) :1470-1477
[14]   Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings [J].
Marcus, Julia L. ;
Volk, Jonathan E. ;
Pinder, Jess ;
Liu, Albert Y. ;
Bacon, Oliver ;
Hare, C. Bradley ;
Cohen, Stephanie E. .
CURRENT HIV/AIDS REPORTS, 2016, 13 (02) :116-124
[15]   Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review [J].
Mayer, Kenneth H. ;
Agwu, Allison ;
Malebranche, David .
ADVANCES IN THERAPY, 2020, 37 (05) :1778-1811
[16]   PrEP 1.0 and Beyond: Optimizing a Biobehavioral Intervention [J].
Mayer, Kenneth H. ;
Allan-Blitz, Lao-Tzu .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 :S113-S117
[17]   Breaking Inertia: Movement Along the PrEP Cascade in a Longitudinal US National Cohort of Sexual Minority Individuals at Risk for HIV [J].
Mehrotra, Megha L. ;
Westmoreland, Drew A. ;
Patel, Viraj V. ;
Hojilla, J. Carlo ;
Grov, Christian .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 86 (05) :e118-e125
[18]  
Nash D. S., J MEDICAL INTERNET R
[19]   Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States [J].
Parsons, Jeffrey T. ;
Rendina, Jonathon ;
Lassiter, Jonathan M. ;
Whitfield, Thomas H. F. ;
Starks, Tyrel J. ;
Grov, Christian .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (03) :285-292
[20]   The HIV Pre-exposure Prophylaxis (PrEP) Cascade at NYC Sexual Health Clinics: Navigation Is the Key to Uptake [J].
Pathela, Preeti ;
Jamison, Kelly ;
Blank, Susan ;
Daskalakis, Demetre ;
Hedberg, Trevor ;
Borges, Christine .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 83 (04) :357-364